The risk of venous thromboembolism was two times higher in women with polycystic ovary syndrome who took oral contraceptives compared with other women who used oral contraceptives. Researchers looked at records from a health insurance database that includes 43,500 women with polycystic ovary syndrome. The study appeared online in the Canadian Medical Association Journal.
Hormone disorder plus contraceptive use raises women's clot risk
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan